Automated Retinal Image Analysis System (ARIAS) are built to find early changes to blood vessels and the circulatory system in the most non-invasive way possible; through a single retinal image. These FDA-cleared technologies promise to expand access, improve efficiency, and ultimately prevent vision loss by bringing screening directly to patients where they receive their primary care. Read more on how they are cost effectively closing care gaps. https://hubs.li/Q04lT-hs0
Optomed US
Medical Equipment Manufacturing
Alpharetta, Georgia 1,154 followers
Health care technology company and a leading provider of handheld fundus cameras and software solutions.
About us
Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases such as rapidly increasing diabetic retinopathy. Optomed was founded in Oulu, Finland in 2004 by Seppo Kopsala Optomed’s CEO, with the vision to design and produce a smaller and more affordable fundus camera than traditionally used desktop cameras, which would improve the efficiency of the eye screening of diabetics. In the early years, the operations were focused on research and development with a long-term perspective and sales activities were limited. At the beginning of the journey, Optomed developed three early product generations. In 2013, Optomed reached a major milestone when it launched the world’s first handheld fundus camera meeting the fundus camera standard ISO 10940 resolution requirements, Smartscope PRO. In 2017, Optomed launched its fifth handheld fundus camera generation, Optomed Aurora.
- Website
-
http://www.optomed.com/us
External link for Optomed US
- Industry
- Medical Equipment Manufacturing
- Company size
- 11-50 employees
- Headquarters
- Alpharetta, Georgia
- Type
- Privately Held
Locations
-
Primary
Get directions
11675 Great Oaks Way
Alpharetta, Georgia 30022, US
Employees at Optomed US
Updates
-
What changes when handheld fundus imaging becomes available at the ED? Schwartz et al. (2025) explored the use of a handheld fundus camera by neurology residents in inpatient care at Stanford University. The result wasn’t just a more detailed view of the optic disc, but a more straightforward workflow. Without imaging: ➡️ Neurology examines → uncertainty → ophthalmology consult → delays With bedside imaging: ➡️ Neurology captures images → immediate insight → faster decisions In fact, clinicians reported: ✅ Improved triage decisions ✅Reduced need for ophthalmology consults ✅ Potential to shorten length of stay This is where portable imaging makes a difference: enabling faster, coordinated, more informed decisions at the front line. #Neurology #HandheldFundusCamera #PointOfCare #ED #Optomed https://hubs.li/Q04jfVnM0
-
Performing Aurora AEYE scans meet MIPS quality measures by themselves; no additional CPT II codes needed. https://hubs.li/Q04jfsPW0 #OptomedUS #AEYEHealth #AuroraAEYE #DiabeticRetinopathy
-
Patient satisfaction with Aurora AEYE is 92%, preferring the immediate results it provides. They felt its use could improve accuracy, reduce human errors, and keep personal information confidential. https://hubs.li/Q04jfl8D0
-
Optomed cameras were implemented into inpatient medical center which resulted in: ☑ Increased confidence in staff ability eye structure identification, description, and interpretation. ☑ Improved fundus visualization ☑ Aiding in triage, sharing images with offsite staff ☑ Reduced length of stay ☑ Reduced ophthalmology consultations ☑ Reduced unnecessary testing ☑ Increased patient health literacy https://hubs.li/Q04jfrCK0
-
Up to 98% of diabetes-related vision loss is preventable, yet only about 50% of people with diabetes get their eyes screened annually. AI-powered handheld imaging is changing that: → screening anywhere → faster diagnosis → better outcomes #GlobalBusinesMedia #AEYEHealth #OptomedUS #AuroraAEYE https://hubs.li/Q04lYx7G0
-
Autonomous AI DR screening systems like the Aurora AEYE allow the expert knowledge of an eye care specialist to be in the hands of a primary care physician or endocrinologist. Putting an FDA-cleared high accuracy screening system where the patient is being seen for their regular diabetes appointment has the possibility to drastically increase adherence to annual diabetic eye exams and close care gaps. #OptomedUS #AEYEHealth #AuroraAEYE #DiabeticRetinopathy
-
-
Oculomics is a new and exciting advancement using retinal images to dive deeper into various health risks and systemic disease identification. This study found that retinal age derived from a single fundus photograph provides a scalable and clinically deployed biomarker of biological ageing. This may enable screening for cardiometabolic and other ageing-related diseases in routine ocular imaging workflows. Optomed handheld fundus cameras are happy to be part of the future in enabling eye screening for all. https://hubs.li/Q04jdJDP0
-
Places with limited access to ophthalmologists will benefit from AI systems for DR screening, especially for rural regions. Patients who live two hours away from an eye doctor are less likely to make the trip if they think their vision is fine. However, receiving a positive result within seconds at a primary care visit may motivate them to follow up with an ophthalmologist. #OptomedUS #AEYEHealth #AuroraAEYE #DiabeticRetinopathy
-
-
We’re proud to be a sponsor of the ADA Step Out Walk in Baltimore! Supporting the American Diabetes Association’s mission to prevent and cure diabetes—and improve the lives of those living with it—is incredibly important to us. Thank you to everyone walking, volunteering, and raising awareness. Together, we’re making a difference in our community. 💙 #ADA #Baltimore #AuroraAEYE #OptomedUS #AEYEHealth
-